Search research articles
Contact Us
Filters
Showing results (471-480 of 595) with videos related to
Page
of 60
Sort By:
Frontiers in Artificial Intelligence
|
February 2, 2026
Artificial intelligence and precision medicine: a pilot study predicting optimal ceftaroline dosage for pediatric patients
Maria Frasca, Gianluca Gazzaniga, Agnese Graziosi, et al.
Oncology Reports
|
April 10, 2003
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes
Giovanni Mantovani, Elena Massa, Giorgio Astara, et al.
International Journal of Oncology
|
January 15, 2002
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity
Giovanni Mantovani, Ernesto Proto, Elena Massa, et al.
ESMO Open
|
April 10, 2019
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fucà, Giulia Galli, Marta Poggi, et al.
Cancers
|
April 3, 2021
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, et al.
Glia
|
August 1, 2022
Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells
Christophe Boudesco, Annelies Nonneman, Alessandro Cinti, et al.
Diabetes, Obesity & Metabolism
|
September 30, 2025
ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
Sara Russo, Luca Proto, Manoel Galvao Neto, et al.
Clinical Lung Cancer
|
April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results
Filippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
ESMO Open
|
May 30, 2020
<i>LKB1</i> mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
Claudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.
Cell Death & Disease
|
October 24, 2020
CSF1R signaling is a regulator of pathogenesis in progressive MS
Nellwyn Hagan, John L Kane, Deepak Grover, et al.
Page
of 60
Search research articles
Search
Showing results (471-480 of 595) with videos related to
Sort By:
Page
of 60
Frontiers in Artificial Intelligence
|
February 2, 2026
Artificial intelligence and precision medicine: a pilot study predicting optimal ceftaroline dosage for pediatric patients
Maria Frasca, Gianluca Gazzaniga, Agnese Graziosi, et al.
Oncology Reports
|
April 10, 2003
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes
Giovanni Mantovani, Elena Massa, Giorgio Astara, et al.
International Journal of Oncology
|
January 15, 2002
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity
Giovanni Mantovani, Ernesto Proto, Elena Massa, et al.
ESMO Open
|
April 10, 2019
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fucà, Giulia Galli, Marta Poggi, et al.
Cancers
|
April 3, 2021
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, et al.
Glia
|
August 1, 2022
Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells
Christophe Boudesco, Annelies Nonneman, Alessandro Cinti, et al.
Diabetes, Obesity & Metabolism
|
September 30, 2025
ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
Sara Russo, Luca Proto, Manoel Galvao Neto, et al.
Clinical Lung Cancer
|
April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results
Filippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
ESMO Open
|
May 30, 2020
<i>LKB1</i> mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
Claudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.
Cell Death & Disease
|
October 24, 2020
CSF1R signaling is a regulator of pathogenesis in progressive MS
Nellwyn Hagan, John L Kane, Deepak Grover, et al.
Page
of 60